GlassScriptPrepare for your visit
Robert J Bonasera
Gastroenterology (Internal Medicine) · Garden City, NY · NPI 1073537767
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$3,337.15
in general payments reported to CMS, 2019-2025 · $1,140 in 2025
The $1,140 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $1,153.31
- Janssen Pharmaceuticals, INC $498.07
- Janssen Biotech, INC. $322.54
- Novo Nordisk INC $295.33
- Pfizer INC. $251.65
- Madrigal Pharmaceuticals $168.60
Drugs and devices associated with these payments
Avycaz Skyrizi Teflaro Rinvoq Dalvance Wegovy Velsipity Tremfya Xarelto Rezdiffra Emblaveo Xeljanz
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Robert Bonasera listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/320447/robert-j-bonasera